Contribution of neuraminidase of influenza viruses to the sensitivity to serum inhibitors and reassortment efficiency

被引:0
|
作者
Kiseleva, I. V. [1 ]
Larionova, N. V. [1 ]
Bazhenova, E. A. [1 ]
Fedorova, E. A. [1 ]
Dubrovina, I. A. [1 ]
Isakova-Sivak, I. N. [1 ]
Rudenko, L. G. [1 ]
机构
[1] Russian Acad Med Sci, Dept Virol, Inst Expt Med, St Petersburg 197376, Russia
关键词
influenza virus; live attenuated influenza vaccine; neuraminidase; serum inhibitors; reassortment; NONSPECIFIC INHIBITORS; PHENOTYPIC FEATURES; IMMUNOGENICITY; HEMAGGLUTININ; EFFICACY; VACCINES; STRAINS;
D O I
10.3103/S0891416814030045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Live attenuated influenza vaccine (LAIV) consists of reassortant viruses with hemagglutinin (HA) and neuraminidase (NA) gene segments inherited from the circulating wild-type (WT) parental viruses and six internal protein-encoding gene segments from cold-adapted attenuated master donor viruses (genome composition 6 : 2). In this study, we describe the difficulties in development of LAIV strains depending on the phenotypic peculiarities of the WT viruses used for reassortment. Genomic-composition analysis of 849 reassortants revealed that over 80% of reassortants based on the inhibitor-resistant WT viruses inherited WT NA as compared to 26% of reassortants based on the inhibitor-sensitive WT viruses. In addition, the highest percentage of vaccine genotype reassortants was achieved when WT parental viruses were resistant to nonspecific serum inhibitors. We show that NA may play a role in the influenza virus' sensitivity to a nonspecific serum inhibitors. Replacing the NA of the inhibitor-sensitive WT virus with the NA of the inhibitor-resistant master donor virus significantly decreased the sensitivity of the resulting reassortant virus to nonspecific inhibitors.
引用
收藏
页码:130 / 138
页数:9
相关论文
共 50 条
  • [31] Neuraminidase inhibitor resistance in influenza viruses
    Reece, Phillip Andrew
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (10) : 1577 - 1586
  • [32] Non-random reassortment in human influenza A viruses
    Rabadan, Raul
    Levine, Arnold J.
    Krasnitz, Michael
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2008, 2 (01) : 9 - 22
  • [33] Neuraminidase inhibitors for treatment of influenza
    Zwillenberg, Marc
    Tang, Eric
    Quaas, Joshua
    ACADEMIC EMERGENCY MEDICINE, 2021, 28 (10) : 1195 - 1197
  • [34] Reassortment and evolution of current human influenza A and B viruses
    Xu, XY
    Lindstrom, SE
    Shaw, MW
    Smith, CB
    Hall, HE
    Mungall, BA
    Subbarao, K
    Cox, NJ
    Klimov, A
    VIRUS RESEARCH, 2004, 103 (1-2) : 55 - 60
  • [35] Neuraminidase Inhibitors and Influenza Infection
    Osthoff, Michael
    Erb, Stefan
    JAMA INTERNAL MEDICINE, 2016, 176 (03) : 415 - 415
  • [36] Influenza A, pregnancy and neuraminidase inhibitors
    Montane, Eva
    Lecumberri, Josep
    Luisa Pedro-Botet, Maria
    MEDICINA CLINICA, 2011, 136 (15): : 688 - 693
  • [37] Neuraminidase inhibitors in the therapy of influenza
    Fladerer, P
    Wenisch, C
    ACTA MEDICA AUSTRIACA, 2000, 27 (05) : 133 - 140
  • [38] Prescription of neuraminidase inhibitors for influenza
    Madeley, D
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2003, 96 (04) : 207 - 208
  • [39] Treatment of influenza with neuraminidase inhibitors
    Beard, Kate R.
    Brendish, Nathan J.
    Clark, Tristan W.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2018, 31 (06) : 514 - 519
  • [40] Influenza virus neuraminidase inhibitors
    Gubareva, LV
    Kaiser, L
    Hayden, FG
    LANCET, 2000, 355 (9206): : 827 - 835